Used in research to specifically target and inhibit DDR1 (Discoidin Domain Receptor 1), this antibody helps study the role of DDR1 in collagen signaling, cell adhesion, migration, and tissue remodeling. It is widely applied in cancer research, particularly in understanding tumor progression, metastasis, and stromal interactions in carcinomas such as breast, lung, and renal cancers. The antibody is also employed in fibrosis studies, including kidney and lung fibrosis, where DDR1 activation contributes to extracellular matrix deposition. It serves as a critical tool in validating DDR1 as a therapeutic target and in the development of DDR1-blocking drugs. Additionally, it is used in flow cytometry, immunoprecipitation, and immunohistochemistry to detect DDR1 expression in various cell types and tissues.